Imagion Biosystems Limited has lodged Appendix 3X, Initial Director’s Interest Notice, with the Australian Securities Exchange.
View the Initial Director’s Interest Notice.
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it